AI Can't Deliver Precision Medicine If Women's Biology Is Missing From the Data
Boston, MA -- November 2026: Precision medicine is only as precise as the data it is built on. Yet some of the biological variables that shape women's health, from hormonal changes to menstrual cycles and menopause, have historically been poorly represented in the evidence used to understand disease, predict risk and develop treatment.
That is the challenge Kimberly Rosen, Executive Director, Clinical Development at Organon, will bring to Women's HealthX this December as part of a timely discussion on integrating female-specific data into research, AI and clinical practice.
Rosen brings an unusual perspective to that conversation. An OB/GYN by training, she has spent more than two decades working at the intersection of clinical science and pharmaceutical strategy, with experience spanning Medical Affairs, Clinical Development, product development, international regulatory approvals and commercial launches.
Precision medicine has a blind spot when the data beneath it fails to capture female-specific biology.
At Women's HealthX, the conversation moves beyond simply recognising that data gap. The panel will examine what happens when cycle, hormonal and menopause data are incorporated into clinical and AI models, and how female-specific biomarkers could help improve predictive accuracy in diagnosis and treatment.
That question is becoming increasingly important as healthcare puts greater weight behind data-driven decision-making and artificial intelligence. Better algorithms alone cannot solve gaps that originate in the information available to them. Building more representative models means considering what is measured, what has historically been missed, and how evidence can better reflect the women those systems are intended to serve.
Rosen's experience across both clinical practice and pharmaceutical development brings that challenge firmly into the real world: how better women's health data moves from research into development and, ultimately, clinical practice.
Join Kimberly Rosen and leaders from across healthcare, research, technology and industry at Women's HealthX, December 3-4 at Encore Boston Harbor.
Women's HealthX 2026 | From Rhetoric to Results
Encore Boston Harbor | December 3-4 2026
Move beyond the headlines shaping women's health to examine the research, clinical models, investment decisions and technologies determining what happens next. Join leaders spanning health systems, life sciences, research, health plans, employers and innovation in Boston this December.